Log in to save to my catalogue

A Theranostic Approach to Imaging and Treating Melanoma with 203 Pb/ 212 Pb-Labeled Antibody Targeti...

A Theranostic Approach to Imaging and Treating Melanoma with 203 Pb/ 212 Pb-Labeled Antibody Targeti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_37568672

A Theranostic Approach to Imaging and Treating Melanoma with 203 Pb/ 212 Pb-Labeled Antibody Targeting Melanin

About this item

Full title

A Theranostic Approach to Imaging and Treating Melanoma with 203 Pb/ 212 Pb-Labeled Antibody Targeting Melanin

Publisher

Switzerland

Journal title

Cancers, 2023-07, Vol.15 (15)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

Metastatic melanoma is a deadly disease that claims thousands of lives each year despite the introduction of several immunotherapeutic agents into the clinic over the past decade, inspiring the development of novel therapeutics and the exploration of combination therapies. Our investigations target melanin pigment with melanin-specific radiolabeled...

Alternative Titles

Full title

A Theranostic Approach to Imaging and Treating Melanoma with 203 Pb/ 212 Pb-Labeled Antibody Targeting Melanin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_37568672

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_37568672

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers15153856

How to access this item